VHT holdings
All 407 positions of Vanguard Health Care ETF.
Positions
407
Top 10 weight
51.9%
Effective holdings
23.0
1 / sum of squared weights
In stocks
99.8%
In bonds
0.0%
Outside the US
0.0%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | Equity | 14.04% | $2.7B | 2,413,444 | US |
| 2 | JNJJohnson & Johnson | Equity | 8.47% | $1.6B | 7,135,556 | US |
| 3 | ABBVABBVIE INC. | Equity | 6.09% | $1.2B | 5,307,975 | US |
| 4 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 5.45% | $1.0B | 2,720,656 | US |
| 5 | MRKMerck & Co., Inc. | Equity | 4.66% | $885M | 7,454,549 | US |
| 6 | TMOThermo Fisher Scientific, Inc. | Equity | 2.93% | $556M | 1,128,374 | US |
| 7 | AMGNAmgen Inc | Equity | 2.87% | $545M | 1,617,212 | US |
| 8 | GILDGilead Sciences Inc | Equity | 2.64% | $501M | 3,726,237 | US |
| 9 | ISRGIntuitive Surgical Inc. | Equity | 2.38% | $452M | 1,064,672 | US |
| 10 | PFEPfizer Inc. | Equity | 2.35% | $447M | 17,075,747 | US |
| 11 | ABTAbbott Laboratories | Equity | 2.35% | $447M | 5,222,149 | US |
| 12 | BMYBristol-Myers Squibb Co. | Equity | 1.84% | $350M | 6,114,287 | US |
| 13 | DHRDanaher Corporation | Equity | 1.84% | $349M | 1,909,151 | US |
| 14 | CVSCVS HEALTH CORPORATION | Equity | 1.83% | $347M | 3,812,997 | US |
| 15 | VRTXVertex Pharmaceuticals Inc | Equity | 1.80% | $341M | 762,060 | US |
| 16 | SYKStryker Corporation | Equity | 1.66% | $315M | 1,033,559 | US |
| 17 | MDTMedtronic plc | Equity | 1.50% | $284M | 3,849,568 | US |
| 18 | MCKMcKesson Corporation | Equity | 1.45% | $275M | 370,665 | US |
| 19 | ELVElevance Health, Inc. | Equity | 1.35% | $257M | 653,140 | US |
| 20 | CIThe Cigna Group | Equity | 1.17% | $223M | 802,292 | US |
| 21 | BSXBoston Scientific Corp. | Equity | 1.13% | $215M | 4,452,909 | US |
| 22 | REGNRegeneron Pharmaceuticals Inc | Equity | 1.00% | $191M | 310,237 | US |
| 23 | HCAHCA Healthcare, Inc. | Equity | 0.96% | $182M | 479,764 | US |
| 24 | EWEdwards Lifesciences Corp | Equity | 0.79% | $151M | 1,742,975 | US |
| 25 | CORCencora, Inc. | Equity | 0.79% | $149M | 553,417 | US |
| 26 | CAHCardinal Health, Inc. | Equity | 0.74% | $140M | 713,505 | US |
| 27 | IDXXIdexx Laboratories Inc | Equity | 0.71% | $135M | 239,830 | US |
| 28 | BDXBecton, Dickinson and Co. | Equity | 0.66% | $126M | 855,933 | US |
| 29 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 0.63% | $120M | 396,853 | US |
| 30 | AAgilent Technologies Inc. | Equity | 0.61% | $115M | 851,463 | US |
| 31 | WATWaters Corp | Equity | 0.60% | $113M | 295,436 | US |
| 32 | HUMHumana Inc. | Equity | 0.58% | $110M | 361,318 | US |
| 33 | ZTSZOETIS INC. | Equity | 0.54% | $103M | 1,323,667 | US |
| 34 | IQVIQVIA Holdings Inc. | Equity | 0.49% | $93M | 511,679 | US |
| 35 | NTRANatera, Inc. Common Stock | Equity | 0.46% | $88M | 394,919 | US |
| 36 | CNCCentene Corporation | Equity | 0.46% | $88M | 1,476,719 | US |
| 37 | DXCMDexCom, Inc. | Equity | 0.46% | $86M | 1,171,689 | US |
| 38 | BIIBBiogen Inc. Common Stock | Equity | 0.45% | $86M | 440,787 | US |
| 39 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 0.45% | $85M | 1,368,877 | US |
| 40 | RMDResMed Inc. | Equity | 0.44% | $84M | 438,370 | US |
| 41 | VEEVVeeva Systems Inc. | Equity | 0.43% | $82M | 468,964 | US |
| 42 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 0.40% | $76M | 485,701 | US |
| 43 | ILMNIllumina Inc | Equity | 0.39% | $75M | 458,727 | US |
| 44 | MTDMettler-Toledo International | Equity | 0.38% | $72M | 61,343 | US |
| 45 | WSTWest Pharmaceutical Services, Inc. | Equity | 0.37% | $70M | 216,149 | US |
| 46 | INSMInsmed, Inc. | Equity | 0.36% | $68M | 640,424 | US |
| 47 | UTHRUnited Therapeutics Corp | Equity | 0.36% | $68M | 122,899 | US |
| 48 | DGXQuest Diagnostics Inc. | Equity | 0.34% | $65M | 334,125 | US |
| 49 | LHLabcorp Holdings Inc. | Equity | 0.34% | $65M | 249,006 | US |
| 50 | STESTERIS plc | Equity | 0.33% | $63M | 294,734 | US |
| 51 | VTRSViatris Inc. Common Stock | Equity | 0.30% | $56M | 3,458,459 | US |
| 52 | ZBHZimmer Biomet Holdings, Inc. | Equity | 0.26% | $49M | 595,291 | US |
| 53 | INCYIncyte Genomics Inc | Equity | 0.26% | $49M | 501,414 | US |
| 54 | NBIXNeurocrine Biosciences Inc | Equity | 0.25% | $47M | 299,296 | US |
| 55 | THCTenet Healthcare Corporation New | Equity | 0.24% | $46M | 263,867 | US |
| 56 | GHGuardant Health, Inc. Common Stock | Equity | 0.23% | $44M | 337,089 | US |
| 57 | MRNAModerna, Inc. Common Stock | Equity | 0.23% | $43M | 911,184 | US |
| 58 | JAZZJazz Pharmaceuticals, Inc. | Equity | 0.20% | $39M | 164,206 | US |
| 59 | EXELExelixis Inc | Equity | 0.20% | $39M | 764,620 | US |
| 60 | COOThe Cooper Companies, Inc. Common Stock | Equity | 0.19% | $36M | 588,251 | US |
| 61 | ALGNAlign Technology Inc | Equity | 0.19% | $36M | 204,686 | US |
| 62 | RVTYRevvity, Inc. | Equity | 0.19% | $36M | 340,595 | US |
| 63 | ELANElanco Animal Health Incorporated Common Stock | Equity | 0.19% | $36M | 1,492,079 | US |
| 64 | PENPenumbra, Inc. | Equity | 0.19% | $36M | 111,694 | US |
| 65 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 0.19% | $35M | 462,321 | US |
| 66 | SOLVSolventum Corporation | Equity | 0.18% | $35M | 468,666 | US |
| 67 | ROIVRoivant Sciences Ltd. Common Shares | Equity | 0.18% | $34M | 1,128,232 | US |
| 68 | EHCEncompass Health Corporation Common Stock | Equity | 0.17% | $32M | 302,081 | US |
| 69 | BMRNBioMarin Pharmaceuticals Inc | Equity | 0.17% | $31M | 548,140 | US |
| 70 | PODDInsulet Corporation | Equity | 0.16% | $31M | 211,250 | US |
| 71 | MEDPMedpace Holdings, Inc. Common Stock | Equity | 0.16% | $30M | 67,568 | US |
| 72 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | Cash | 0.16% | $30M | 297,537 | US |
| 73 | ENSGThe Ensign Group, Inc. | Equity | 0.15% | $29M | 173,943 | US |
| 74 | BAXBaxter International Inc. | Equity | 0.15% | $29M | 1,544,802 | US |
| 75 | BBIOBridgeBio Pharma, Inc. Common Stock | Equity | 0.15% | $29M | 434,291 | US |
| 76 | ARWRArrowhead Research Corporation | Equity | 0.15% | $29M | 367,316 | US |
| 77 | MDLNMedline Inc. Class A common stock | Equity | 0.15% | $28M | 775,489 | US |
| 78 | GMEDGLOBUS MEDICAL INC | Equity | 0.15% | $28M | 336,709 | US |
| 79 | CYTKCytokinetics Inc. | Equity | 0.14% | $27M | 349,860 | US |
| 80 | MOHMolina Healthcare, Inc. | Equity | 0.14% | $27M | 154,404 | US |
| 81 | CRLCharles River Laboratories International, Inc. | Equity | 0.14% | $27M | 147,876 | US |
| 82 | BTSGBrightSpring Health Services, Inc. Common Stock | Equity | 0.14% | $27M | 432,800 | US |
| 83 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 0.13% | $25M | 70,836 | US |
| 84 | AXSMAxsome Therapeutics, Inc | Equity | 0.13% | $25M | 105,207 | US |
| 85 | CORCencora, Inc. | Equity | 0.13% | $24M | 137,148 | US |
| 86 | HSICHenry Schein Inc | Equity | 0.13% | $24M | 318,436 | US |
| 87 | UHSUniversal Health Services, Inc. Class B | Equity | 0.13% | $24M | 165,907 | US |
| 88 | TECHBio-Techne Corp. | Equity | 0.13% | $24M | 468,322 | US |
| 89 | HALOHalozyme Therapeutics, Inc. | Equity | 0.12% | $24M | 353,285 | US |
| 90 | DVADaVita Inc. | Equity | 0.12% | $23M | 116,665 | US |
| 91 | HQYHealthEquity, Inc | Equity | 0.12% | $23M | 256,670 | US |
| 92 | MDGLMadrigal Pharmaceuticals, Inc. Common Stock | Equity | 0.12% | $22M | 44,411 | US |
| 93 | KRYSKrystal Biotech, Inc. Common Stock | Equity | 0.11% | $20M | 65,350 | US |
| 94 | RGENRepligen Corp | Equity | 0.10% | $20M | 160,691 | US |
| 95 | ALKSAlkermes Inc. plc | Equity | 0.10% | $20M | 471,347 | US |
| 96 | LNTHLantheus Holdings, Inc | Equity | 0.10% | $20M | 199,385 | US |
| 97 | CORTCorcept Therapeutics Inc. | Equity | 0.10% | $20M | 284,629 | US |
| 98 | BRKRBruker Corporation | Equity | 0.10% | $19M | 320,384 | US |
| 99 | AVTRAvantor, Inc. | Equity | 0.10% | $19M | 2,050,618 | US |
| 100 | PCVXVaxcyte, Inc. Common Stock | Equity | 0.10% | $18M | 354,408 | US |
| 101 | CHEChemed Corporation | Equity | 0.10% | $18M | 42,488 | US |
| 102 | GKOSGlaukos Corporation | Equity | 0.09% | $18M | 172,558 | US |
| 103 | BIOBio-Rad Laboratories, Inc.Class A | Equity | 0.09% | $17M | 55,986 | US |
| 104 | TGTXTG Therapeutics, Inc. | Equity | 0.09% | $17M | 453,218 | US |
| 105 | TFXTeleflex Incorporated | Equity | 0.09% | $17M | 132,807 | US |
| 106 | PTCTPTC Therapeutics, Inc. | Equity | 0.08% | $16M | 216,651 | US |
| 107 | HIMSHims & Hers Health, Inc. | Equity | 0.08% | $15M | 591,888 | US |
| 108 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | Equity | 0.08% | $15M | 170,218 | US |
| 109 | PTGXProtagonist Therapeutics, Inc | Equity | 0.08% | $15M | 150,485 | US |
| 110 | TEMTempus AI, Inc. Class A Common Stock | Equity | 0.07% | $14M | 278,247 | US |
| 111 | LGNDLigand Pharmaceuticals Inc. | Equity | 0.07% | $14M | 59,358 | US |
| 112 | NUVLNuvalent, Inc. Class A Common Stock | Equity | 0.07% | $13M | 119,928 | US |
| 113 | SHCSotera Health Company Common Stock | Equity | 0.07% | $13M | 834,470 | US |
| 114 | LIVNLivaNova PLC Ordinary Shares | Equity | 0.06% | $12M | 164,205 | US |
| 115 | TWSTTwist Bioscience Corporation Common Stock | Equity | 0.06% | $12M | 181,056 | US |
| 116 | TVTXTravere Therapeutics, Inc. Common Stock | Equity | 0.06% | $12M | 255,020 | US |
| 117 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share | Equity | 0.06% | $12M | 496,093 | US |
| 118 | KYMRKymera Therapeutics, Inc. Common Stock | Equity | 0.06% | $12M | 143,130 | US |
| 119 | MIRMMirum Pharmaceuticals, Inc. Common Stock | Equity | 0.06% | $12M | 113,338 | US |
| 120 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | Cash | 0.06% | $11M | 11,498,367 | US |
| 121 | INDVIndivior Pharmaceuticals, Inc. Common Stock | Equity | 0.06% | $11M | 318,087 | US |
| 122 | LQDALiquidia Corporation Common Stock | Equity | 0.06% | $11M | 182,678 | US |
| 123 | MMSIMerit Medical Systems Inc | Equity | 0.06% | $11M | 177,707 | US |
| 124 | IRTCiRhythm Holdings, Inc. Common Stock | Equity | 0.06% | $11M | 96,954 | US |
| 125 | RDNTRadNet, Inc. Common Stock | Equity | 0.06% | $11M | 198,220 | US |
| 126 | VCYTVeracyte, Inc. | Equity | 0.06% | $11M | 237,223 | US |
| 127 | CPRXCatalyst Pharmaceutical Inc. | Equity | 0.06% | $11M | 349,753 | US |
| 128 | SYRESpyre Therapeutics, Inc. Common Stock | Equity | 0.06% | $11M | 146,746 | US |
| 129 | VKTXViking Therapeutics, Inc | Equity | 0.06% | $11M | 324,654 | US |
| 130 | OGNOrganon & Co. | Equity | 0.05% | $10M | 778,961 | US |
| 131 | OPCHOption Care Health, Inc. Common Stock | Equity | 0.05% | $10.0M | 478,091 | US |
| 132 | DNTHDianthus Therapeutics, Inc. Common Stock | Equity | 0.05% | $9.8M | 104,868 | US |
| 133 | ICUIICU Medical Inc | Equity | 0.05% | $9.6M | 70,604 | US |
| 134 | CRNXCrinetics Pharmaceuticals, Inc. | Equity | 0.05% | $9.6M | 268,667 | US |
| 135 | HAEHaemonetics Corporation | Equity | 0.05% | $9.5M | 140,454 | US |
| 136 | ITGRInteger Holdings Corporation | Equity | 0.05% | $9.4M | 105,460 | US |
| 137 | APGEApogee Therapeutics, Inc. Common Stock | Equity | 0.05% | $9.4M | 114,611 | US |
| 138 | SRRKScholar Rock Holding Corporation Common Stock | Equity | 0.05% | $9.2M | 187,254 | US |
| 139 | BEAMBeam Therapeutics Inc. Common Stock | Equity | 0.05% | $9.0M | 274,310 | US |
| 140 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 0.05% | $8.9M | 314,908 | US |
| 141 | COGTCogent Biosciences, Inc. Common Stock | Equity | 0.05% | $8.8M | 252,475 | US |
| 142 | DNLIDenali Therapeutics Inc. Common Stock | Equity | 0.05% | $8.8M | 416,498 | US |
| 143 | BKDBrookdale Senior Living, Inc. | Equity | 0.05% | $8.7M | 676,424 | US |
| 144 | CONConcentra Group Holdings Parent, Inc. | Equity | 0.05% | $8.6M | 347,193 | US |
| 145 | CELCCelcuity Inc. Common Stock | Equity | 0.04% | $8.3M | 62,506 | US |
| 146 | SMMTSummit Therapeutics Inc. Common Stock | Equity | 0.04% | $8.1M | 462,390 | US |
| 147 | IMVTImmunovant, Inc. Common Stock | Equity | 0.04% | $8.1M | 242,266 | US |
| 148 | CGONCG Oncology, Inc. Common stock | Equity | 0.04% | $8.0M | 128,368 | US |
| 149 | SUPNSupernus Pharmaceuticals, Inc. | Equity | 0.04% | $7.9M | 171,965 | US |
| 150 | DOCSDoximity, Inc. | Equity | 0.04% | $7.9M | 370,826 | US |
| 151 | IBRXImmunityBio, Inc. Common Stock | Equity | 0.04% | $7.8M | 1,033,729 | US |
| 152 | ALHCAlignment Healthcare, Inc. Common Stock | Equity | 0.04% | $7.7M | 504,688 | US |
| 153 | ACADAcadia Pharmaceuticals Inc. | Equity | 0.04% | $7.7M | 356,677 | US |
| 154 | GRALGRAIL, Inc. Common Stock | Equity | 0.04% | $7.5M | 105,304 | US |
| 155 | NHCNational Healthcare Corp. | Equity | 0.04% | $7.3M | 39,517 | US |
| 156 | ARQTArcutis Biotherapeutics, Inc. Common Stock | Equity | 0.04% | $7.1M | 330,827 | US |
| 157 | IDYAIDEAYA Biosciences, Inc. Common Stock | Equity | 0.04% | $7.0M | 236,805 | US |
| 158 | PBHPrestige Consumer Healthcare Inc. | Equity | 0.04% | $6.9M | 144,254 | US |
| 159 | WAYWaystar Holding Corp. Common Stock | Equity | 0.04% | $6.9M | 344,105 | US |
| 160 | DYNDyne Therapeutics, Inc. Common Stock | Equity | 0.04% | $6.7M | 345,926 | US |
| 161 | RCUSArcus Biosciences, Inc. | Equity | 0.03% | $6.6M | 260,242 | US |
| 162 | ERASErasca, Inc. Common Stock | Equity | 0.03% | $6.5M | 510,022 | US |
| 163 | TMDXTransMedics Group, Inc. Common Stock | Equity | 0.03% | $6.5M | 97,276 | US |
| 164 | PRVAPrivia Health Group, Inc. Common Stock | Equity | 0.03% | $6.3M | 295,109 | US |
| 165 | CLDXCelldex Therapeutics, Inc | Equity | 0.03% | $6.3M | 201,361 | US |
| 166 | PGNYProgyny, Inc. Common Stock | Equity | 0.03% | $6.3M | 246,175 | US |
| 167 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.03% | $6.3M | 475,933 | US |
| 168 | XRAYDENTSPLY SIRONA Inc. | Equity | 0.03% | $6.3M | 598,187 | US |
| 169 | RAREUltragenyx Pharmaceutical Inc. | Equity | 0.03% | $6.2M | 261,055 | US |
| 170 | IMNMImmunome, Inc. | Equity | 0.03% | $6.1M | 281,546 | US |
| 171 | LMATLeMaitre Vascular, Inc. | Equity | 0.03% | $6.1M | 64,683 | US |
| 172 | ACHCAcadia Healthcare Company, Inc. | Equity | 0.03% | $6.1M | 263,320 | US |
| 173 | NKTRNektar Therapeutics | Equity | 0.03% | $6.0M | 92,000 | US |
| 174 | OMCLOmnicell Inc | Equity | 0.03% | $5.9M | 134,699 | US |
| 175 | DFTXDefinium Therapeutics, Inc. Common Shares | Equity | 0.03% | $5.8M | 241,171 | US |
| 176 | TARSTarsus Pharmaceuticals, Inc. Common Stock | Equity | 0.03% | $5.7M | 96,306 | US |
| 177 | CRVLCorvel Corp | Equity | 0.03% | $5.7M | 92,316 | US |
| 178 | ADMAADMA Biologics, Inc. | Equity | 0.03% | $5.7M | 713,766 | US |
| 179 | NEOGNeogen Corp | Equity | 0.03% | $5.6M | 620,166 | US |
| 180 | MDPediatrix Medical Group, Inc. | Equity | 0.03% | $5.6M | 257,771 | US |
| 181 | BCRXBioCryst Pharmaceuticals Inc | Equity | 0.03% | $5.5M | 622,134 | US |
| 182 | SEMSELECT MEDICAL HOLDINGS CORP | Equity | 0.03% | $5.5M | 334,394 | US |
| 183 | ORKAOruka Therapeutics, Inc. Common Stock | Equity | 0.03% | $5.5M | 94,188 | US |
| 184 | AXGNAxogen, Inc. Common Stock | Equity | 0.03% | $5.5M | 138,165 | US |
| 185 | EWTXEdgewise Therapeutics, Inc. Common Stock | Equity | 0.03% | $5.4M | 158,966 | US |
| 186 | NVCRNovoCure Limited Ordinary Shares | Equity | 0.03% | $5.4M | 318,559 | US |
| 187 | NTLAIntellia Therapeutics, Inc | Equity | 0.03% | $5.4M | 384,014 | US |
| 188 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.03% | $5.4M | 384,116 | US |
| 189 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 0.03% | $5.3M | 298,880 | US |
| 190 | KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares | Equity | 0.03% | $5.2M | 108,383 | US |
| 191 | ADPTAdaptive Biotechnologies Corporation Common Stock | Equity | 0.03% | $5.2M | 344,428 | US |
| 192 | PACSPACS Group, Inc. | Equity | 0.03% | $5.2M | 141,119 | US |
| 193 | AUPHAurinia Pharmaceuticals Inc | Equity | 0.03% | $5.2M | 336,035 | US |
| 194 | ASTHAstrana Health Inc. Common Stock | Equity | 0.03% | $5.1M | 135,360 | US |
| 195 | ADUSAddus HomeCare Corp. | Equity | 0.03% | $5.1M | 55,462 | US |
| 196 | IRONDisc Medicine, Inc. Common Stock | Equity | 0.03% | $5.1M | 72,990 | US |
| 197 | CLOVClover Health Investments, Corp | Equity | 0.03% | $5.1M | 1,273,572 | US |
| 198 | VCELVericel Corporation | Equity | 0.03% | $5.1M | 151,746 | US |
| 199 | AGIOAgios Pharmaceuticals, Inc. | Equity | 0.03% | $4.9M | 166,145 | US |
| 200 | UFPTUFP Technologies Inc | Equity | 0.03% | $4.8M | 21,947 | US |
| 201 | SNDXSyndax Pharmaceuticals, Inc. | Equity | 0.03% | $4.8M | 245,176 | US |
| 202 | RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.03% | $4.8M | 1,327,939 | US |
| 203 | PRGOPERRIGO COMPANY PLC | Equity | 0.02% | $4.6M | 414,128 | US |
| 204 | INVAInnoviva, Inc. Common Stock | Equity | 0.02% | $4.6M | 212,928 | US |
| 205 | Newamsterdam Pharma Co NV | Equity | 0.02% | $4.6M | 135,312 | US |
| 206 | NVAXNovavax Inc | Equity | 0.02% | $4.6M | 415,035 | US |
| 207 | PRCTPROCEPT BioRobotics Corporation Common Stock | Equity | 0.02% | $4.4M | 167,890 | US |
| 208 | ARDXArdelyx, Inc. | Equity | 0.02% | $4.4M | 727,249 | US |
| 209 | MLYSMineralys Therapeutics, Inc. Common Stock | Equity | 0.02% | $4.3M | 137,400 | US |
| 210 | OCULOcular Therapeutix, Inc. | Equity | 0.02% | $4.3M | 479,653 | US |
| 211 | BHVNBiohaven Ltd. | Equity | 0.02% | $4.3M | 392,136 | US |
| 212 | FTREFortrea Holdings Inc. Common Stock | Equity | 0.02% | $4.3M | 276,292 | US |
| 213 | ANIPANI Pharmaceuticals, Inc. | Equity | 0.02% | $4.2M | 53,845 | US |
| 214 | ALMSAlumis Inc. Common Stock | Equity | 0.02% | $4.2M | 193,680 | US |
| 215 | ATRCAtriCure, Inc. | Equity | 0.02% | $4.1M | 149,301 | US |
| 216 | HRMYHarmony Biosciences Holdings, Inc. Common Stock | Equity | 0.02% | $4.1M | 129,532 | US |
| 217 | VERAVera Therapeutics, Inc. Class A Common Stock | Equity | 0.02% | $4.1M | 115,012 | US |
| 218 | NEONeoGenomics, Inc. | Equity | 0.02% | $4.1M | 387,546 | US |
| 219 | NRIXNurix Therapeutics, Inc. Common stock | Equity | 0.02% | $4.1M | 228,970 | US |
| 220 | TRVITrevi Therapeutics, Inc. Common Stock | Equity | 0.02% | $4.1M | 286,762 | US |
| 221 | TDOCTeladoc Health, Inc. | Equity | 0.02% | $4.1M | 532,199 | US |
| 222 | LFSTLifeStance Health Group, Inc. Common Stock | Equity | 0.02% | $4.0M | 525,120 | US |
| 223 | ENOVEnovis Corporation | Equity | 0.02% | $3.9M | 172,038 | US |
| 224 | ELVNEnliven Therapeutics, Inc. Common Stock | Equity | 0.02% | $3.9M | 97,744 | US |
| 225 | IOVAIovance Biotherapeutics, Inc. Common Stock | Equity | 0.02% | $3.8M | 925,025 | US |
| 226 | STOKStoke Therapeutics, Inc. Common Stock | Equity | 0.02% | $3.7M | 119,987 | US |
| 227 | ESTAEstablishment Labs Holdings Inc. | Equity | 0.02% | $3.7M | 52,404 | US |
| 228 | PNTGThe Pennant Group, Inc. Common Stock | Equity | 0.02% | $3.6M | 103,691 | US |
| 229 | TNDMTandem Diabetes Care, Inc. | Equity | 0.02% | $3.5M | 203,604 | US |
| 230 | INSPInspire Medical Systems, Inc. | Equity | 0.02% | $3.5M | 84,309 | US |
| 231 | PVLAPalvella Therapeutics, Inc. Common Stock | Equity | 0.02% | $3.5M | 29,359 | US |
| 232 | CDNACareDx, Inc. | Equity | 0.02% | $3.5M | 152,011 | US |
| 233 | AVNSAvanos Medical, Inc. | Equity | 0.02% | $3.5M | 139,780 | US |
| 234 | AGLagilon health, inc. | Equity | 0.02% | $3.4M | 37,202 | US |
| 235 | VRDNViridian Therapeutics, Inc. Common Stock | Equity | 0.02% | $3.4M | 194,488 | US |
| 236 | RAPPRapport Therapeutics, Inc. Common Stock | Equity | 0.02% | $3.4M | 86,024 | US |
| 237 | VIRVir Biotechnology, Inc. Common Stock | Equity | 0.02% | $3.4M | 351,159 | US |
| 238 | AMNAMN Healthcare Services | Equity | 0.02% | $3.3M | 115,014 | US |
| 239 | CNMDCONMED Corporation | Equity | 0.02% | $3.3M | 93,241 | US |
| 240 | URGNUroGen Pharma Ltd. Ordinary Shares | Equity | 0.02% | $3.3M | 118,284 | US |
| 241 | HROWHarrow, Inc. Common Stock | Equity | 0.02% | $3.3M | 94,443 | US |
| 242 | MNKDMannkind Corporation | Equity | 0.02% | $3.3M | 869,782 | US |
| 243 | COLLCollegium Pharmaceutical, Inc. Common Stock | Equity | 0.02% | $3.2M | 95,192 | US |
| 244 | KODKodiak Sciences Inc Common Stock | Equity | 0.02% | $3.2M | 87,135 | US |
| 245 | IARTIntegra LifeSciences Holdings | Equity | 0.02% | $3.2M | 198,151 | US |
| 246 | NUVBNuvation Bio Inc. | Equity | 0.02% | $3.2M | 661,830 | US |
| 247 | WGSGeneDx Holdings Corp. Class A Common Stock | Equity | 0.02% | $3.2M | 60,640 | US |
| 248 | SGRYSurgery Partners, Inc. Common Stock | Equity | 0.02% | $3.1M | 234,128 | US |
| 249 | XERSXeris Biopharma Holdings, Inc. Common Stock | Equity | 0.02% | $3.1M | 498,772 | US |
| 250 | EYPTEyePoint, Inc. Common Stock | Equity | 0.02% | $3.0M | 224,020 | US |
| 251 | BLFSBioLife Solutions Inc. | Equity | 0.02% | $3.0M | 122,029 | US |
| 252 | SDGRSchrodinger, Inc. Common Stock | Equity | 0.02% | $3.0M | 195,378 | US |
| 253 | HNGEHinge Health, Inc. | Equity | 0.02% | $3.0M | 52,490 | US |
| 254 | TNGXTango Therapeutics, Inc. | Equity | 0.02% | $2.9M | 133,599 | US |
| 255 | USPHUS Physical Therapy Inc | Equity | 0.02% | $2.9M | 45,580 | US |
| 256 | STAAStaar Surgical Co | Equity | 0.02% | $2.9M | 97,427 | US |
| 257 | AHCOAdaptHealth Corp. Common Stock | Equity | 0.02% | $2.9M | 283,546 | US |
| 258 | AZTAAzenta, Inc. | Equity | 0.02% | $2.9M | 124,973 | US |
| 259 | PCRXPacira BioSciences, Inc. Common Stock | Equity | 0.02% | $2.9M | 122,867 | US |
| 260 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $2.8M | 198,058 | US |
| 261 | GRDNGuardian Pharmacy Services, Inc. | Equity | 0.01% | $2.8M | 73,051 | US |
| 262 | ZYMEZymeworks Inc. | Equity | 0.01% | $2.8M | 111,849 | US |
| 263 | BFLYButterfly Network, Inc. | Equity | 0.01% | $2.8M | 609,381 | US |
| 264 | ATECAlphatec Holdings, Inc. | Equity | 0.01% | $2.8M | 356,776 | US |
| 265 | AORTArtivion, Inc. | Equity | 0.01% | $2.7M | 120,290 | US |
| 266 | QDELQuidelOrtho Corporation Common Stock | Equity | 0.01% | $2.7M | 203,903 | US |
| 267 | TSHATaysha Gene Therapies, Inc. Common Stock | Equity | 0.01% | $2.4M | 411,148 | US |
| 268 | KURAKura Oncology, Inc. | Equity | 0.01% | $2.4M | 231,658 | US |
| 269 | OMEROmeros Corporation | Equity | 0.01% | $2.4M | 213,047 | US |
| 270 | ANABAnaptysBio, Inc. Common Stock | Equity | 0.01% | $2.3M | 41,800 | US |
| 271 | PGENPrecigen, Inc. Common Stock | Equity | 0.01% | $2.3M | 527,567 | US |
| 272 | IRMDiRadimed Corporation | Equity | 0.01% | $2.2M | 24,782 | US |
| 273 | ESPREsperion Therapeutics, Inc. | Equity | 0.01% | $2.2M | 713,028 | US |
| 274 | KALVKalVista Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $2.2M | 82,908 | US |
| 275 | CYRXCryoPort, Inc. Common Stock | Equity | 0.01% | $2.2M | 141,893 | US |
| 276 | TALKTalkspace, Inc. Common Stock | Equity | 0.01% | $2.2M | 423,947 | US |
| 277 | WVEWave Life Sciences Ltd. Ordinary Shares | Equity | 0.01% | $2.2M | 334,797 | US |
| 278 | MBXMBX Biosciences, Inc. Common Stock | Equity | 0.01% | $2.1M | 67,443 | US |
| 279 | CERTCertara, Inc. Common Stock | Equity | 0.01% | $2.1M | 358,886 | US |
| 280 | AMPHAmphastar Pharmaceuticals, Inc. | Equity | 0.01% | $2.1M | 110,795 | US |
| 281 | AURAAura Biosciences, Inc. Common Stock | Equity | 0.01% | $2.1M | 279,337 | US |
| 282 | CRVSCorvus Pharmaceuticals, Inc. | Equity | 0.01% | $2.1M | 167,995 | US |
| 283 | ABUSArbutus Biopharma Corporation Common Stock | Equity | 0.01% | $2.1M | 452,223 | US |
| 284 | ANNXAnnexon, Inc. Common Stock | Equity | 0.01% | $1.9M | 355,646 | US |
| 285 | TLRYTilray Brands, Inc. Common Stock | Equity | 0.01% | $1.9M | 347,389 | US |
| 286 | AVBPArriVent BioPharma, Inc. Common Stock | Equity | 0.01% | $1.9M | 62,626 | US |
| 287 | PAHCPhibro Animal Health Corporation Class A | Equity | 0.01% | $1.9M | 61,064 | US |
| 288 | CRMDCorMedix Inc. | Equity | 0.01% | $1.9M | 220,892 | US |
| 289 | OPKOpko Health Inc. | Equity | 0.01% | $1.8M | 1,261,116 | US |
| 290 | CSTLCastle Biosciences, Inc. Common Stock | Equity | 0.01% | $1.8M | 86,840 | US |
| 291 | GLUEMonte Rosa Therapeutics, Inc. Common Stock | Equity | 0.01% | $1.8M | 92,589 | US |
| 292 | MLTXMoonLake Immunotherapeutics Class A Ordinary Shares | Equity | 0.01% | $1.8M | 94,919 | US |
| 293 | TBPHTheravance Biopharma, Inc. | Equity | 0.01% | $1.8M | 113,312 | US |
| 294 | PSNLPersonalis, Inc. Common Stock | Equity | 0.01% | $1.8M | 158,466 | US |
| 295 | BCAXBicara Therapeutics Inc. Common Stock | Equity | 0.01% | $1.8M | 82,868 | US |
| 296 | GERNGeron Corp | Equity | 0.01% | $1.8M | 1,432,603 | US |
| 297 | HSTMHealthStream Inc | Equity | 0.01% | $1.8M | 71,524 | US |
| 298 | PHRPhreesia, Inc. | Equity | 0.01% | $1.8M | 181,081 | US |
| 299 | CERSCerus Corp | Equity | 0.01% | $1.8M | 583,474 | US |
| 300 | XNCRXencor, Inc. | Equity | 0.01% | $1.8M | 149,058 | US |
| 301 | SIBNSI-BONE, Inc. Common Stock | Equity | 0.01% | $1.7M | 124,048 | US |
| 302 | CTMXCytomX Therapeutics, Inc. | Equity | 0.01% | $1.7M | 482,370 | US |
| 303 | ALTAltimmune, Inc. Common Stock | Equity | 0.01% | $1.7M | 567,179 | US |
| 304 | SANASana Biotechnology, Inc. Common Stock | Equity | 0.01% | $1.7M | 520,072 | US |
| 305 | JANXJanux Therapeutics, Inc. Common Stock | Equity | 0.01% | $1.7M | 117,140 | US |
| 306 | MLABMesa Laboratories Inc | Equity | 0.01% | $1.7M | 16,440 | US |
| 307 | TCMDTactile Systems Technology, Inc. | Equity | 0.01% | $1.7M | 67,360 | US |
| 308 | ALLOAllogene Therapeutics, Inc. Common Stock | Equity | 0.01% | $1.6M | 743,762 | US |
| 309 | IRWDIronwood Pharmaceuticals, Inc. - Class A | Equity | 0.01% | $1.6M | 436,023 | US |
| 310 | MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock | Equity | 0.01% | $1.6M | 323,659 | US |
| 311 | PLSEPulse Biosciences, Inc Common Stock (DE) | Equity | 0.01% | $1.5M | 60,556 | US |
| 312 | OLMAOlema Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $1.5M | 112,663 | US |
| 313 | SPRYARS Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $1.5M | 162,048 | US |
| 314 | ARVNArvinas, Inc | Equity | 0.01% | $1.5M | 162,748 | US |
| 315 | CGEMCullinan Therapeutics, Inc. Common Stock | Equity | 0.01% | $1.4M | 88,087 | US |
| 316 | EBSEmergent Biosolutions, Inc. | Equity | 0.01% | $1.4M | 158,276 | US |
| 317 | ANGOAngioDynamics, Inc. | Equity | 0.01% | $1.4M | 124,182 | US |
| 318 | MGTXMeiraGTx Holdings plc Ordinary Shares | Equity | 0.01% | $1.4M | 133,062 | US |
| 319 | PRTAProthena Corporation plc Ordinary Shares | Equity | 0.01% | $1.4M | 136,559 | US |
| 320 | CTKBCytek Biosciences, Inc. Common Stock | Equity | 0.01% | $1.4M | 324,066 | US |
| 321 | PHATPhathom Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $1.3M | 139,582 | US |
| 322 | TYRATyra Biosciences, Inc. Common Stock | Equity | 0.01% | $1.3M | 39,935 | US |
| 323 | KMTSKestra Medical Technologies, Ltd. Common Stock | Equity | 0.01% | $1.3M | 61,828 | US |
| 324 | MDXGMiMedx Group, Inc | Equity | 0.01% | $1.3M | 354,722 | US |
| 325 | VREXVarex Imaging Corporation Common Stock | Equity | 0.01% | $1.3M | 126,613 | US |
| 326 | OCGNOcugen, Inc. Common Stock | Equity | 0.01% | $1.3M | 931,671 | US |
| 327 | FDMT4D Molecular Therapeutics, Inc. Common Stock | Equity | 0.01% | $1.3M | 127,842 | US |
| 328 | XOMAXOMA Royalty Corporation Common Stock | Equity | 0.01% | $1.2M | 29,960 | US |
| 329 | REPLReplimune Group, Inc. | Equity | 0.01% | $1.2M | 139,710 | US |
| 330 | LXRXLexicon Pharmaceuticals, Inc. | Equity | 0.01% | $1.2M | 544,199 | US |
| 331 | CCRNCross Country Healthcare Inc | Equity | 0.01% | $1.2M | 88,002 | US |
| 332 | PACBPacific Biosciences of California, Inc. | Equity | 0.01% | $1.1M | 766,110 | US |
| 333 | CATXPerspective Therapeutics, Inc. | Equity | 0.01% | $1.1M | 288,380 | US |
| 334 | EVHEvolent Health, Inc Class A Common Stock | Equity | 0.01% | $1.1M | 282,147 | US |
| 335 | AVAHAveanna Healthcare Holdings Inc. Common Stock | Equity | 0.01% | $1.1M | 155,434 | US |
| 336 | MYGNMyriad Genetics Inc | Equity | 0.01% | $1.1M | 279,799 | US |
| 337 | ORICOric Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $1.1M | 130,374 | US |
| 338 | VNDAVanda Pharmaceuticals Inc. | Equity | 0.01% | $1.1M | 167,177 | US |
| 339 | FLGTFulgent Genetics, Inc. Common Stock | Equity | 0.01% | $1.1M | 59,307 | US |
| 340 | SVRASavara Inc. | Equity | 0.01% | $1.1M | 206,240 | US |
| 341 | CYHCommunity Health Systems, Inc. | Equity | 0.01% | $1.0M | 379,785 | US |
| 342 | BVSBioventus Inc. Class A Common Stock | Equity | 0.01% | $1.0M | 119,547 | US |
| 343 | EDITEditas Medicine, Inc. Common Stock | Equity | 0.01% | $1.0M | 291,435 | US |
| 344 | CBLLCeriBell, Inc. Common Stock | Equity | 0.01% | $1.0M | 54,529 | US |
| 345 | SEPNSepterna, Inc. Common Stock | Equity | 0.01% | $1.0M | 33,204 | US |
| 346 | DNAGinkgo Bioworks Holdings, Inc. | Equity | 0.01% | $971K | 103,621 | US |
| 347 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.01% | $956K | 269,378 | US |
| 348 | EOLSEvolus, Inc. Common Stock | Equity | 0.00% | $940K | 143,338 | US |
| 349 | RGNXREGENXBIO Inc. | Equity | 0.00% | $908K | 129,557 | US |
| 350 | KIDSOrthoPediatrics Corp. Common Stock | Equity | 0.00% | $895K | 52,143 | US |
| 351 | SLPSimulations Plus, Inc. | Equity | 0.00% | $887K | 51,837 | US |
| 352 | ZBIOZenas BioPharma, Inc. Common Stock | Equity | 0.00% | $878K | 47,733 | US |
| 353 | OFIXOrthofix Medical Inc. Common Stock (DE) | Equity | 0.00% | $872K | 94,025 | US |
| 354 | LABStandard BioTools Inc. Common Stock | Equity | 0.00% | $852K | 741,244 | US |
| 355 | OSUROraSure Technologies Inc | Equity | 0.00% | $842K | 195,698 | US |
| 356 | FATEFate Therapeutics, Inc. | Equity | 0.00% | $831K | 292,658 | US |
| 357 | AVXLAnavex Life Sciences | Equity | 0.00% | $806K | 266,123 | US |
| 358 | ARDTArdent Health, Inc. | Equity | 0.00% | $785K | 85,058 | US |
| 359 | FULCFulcrum Therapeutics, Inc. Common Stock | Equity | 0.00% | $780K | 112,786 | US |
| 360 | AKBAAkebia Therapeutics, Inc. | Equity | 0.00% | $767K | 751,608 | US |
| 361 | RCKTRocket Pharmaceuticals, Inc. Common Stock | Equity | 0.00% | $744K | 242,331 | US |
| 362 | GDRXGoodRx Holdings, Inc. Class A Common Stock | Equity | 0.00% | $741K | 253,611 | US |
| 363 | AVIRAtea Pharmaceuticals, Inc. Common Stock | Equity | 0.00% | $718K | 153,768 | US |
| 364 | RZLTRezolute, Inc. Common Stock (NV) | Equity | 0.00% | $715K | 216,528 | US |
| 365 | OABIOmniAb, Inc. Common Stock | Equity | 0.00% | $695K | 257,460 | US |
| 366 | TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares | Equity | 0.00% | $667K | 41,814 | US |
| 367 | QSIQuantum-Si Incorporated Class A Common Stock | Equity | 0.00% | $642K | 539,508 | US |
| 368 | ARCTArcturus Therapeutics Holdings Inc. Common Stock | Equity | 0.00% | $618K | 78,018 | US |
| 369 | HUMAHumacyte, Inc. Common Stock | Equity | 0.00% | $617K | 474,574 | US |
| 370 | MGNXMacroGenics, Inc. | Equity | 0.00% | $609K | 146,320 | US |
| 371 | UPBUpstream Bio, Inc. Common Stock | Equity | 0.00% | $606K | 72,472 | US |
| 372 | SIGASIGA Technologies Inc. | Equity | 0.00% | $605K | 129,292 | US |
| 373 | ZNTLZentalis Pharmaceuticals, Inc. Common Stock | Equity | 0.00% | $602K | 150,598 | US |
| 374 | EMBCEmbecta Corp. Common Stock | Equity | 0.00% | $571K | 168,963 | US |
| 375 | VSTMVerastem, Inc. | Equity | 0.00% | $556K | 128,379 | US |
| 376 | RXSTRxSight, Inc. Common Stock | Equity | 0.00% | $553K | 103,801 | US |
| 377 | KROSKeros Therapeutics, Inc. Common Stock | Equity | 0.00% | $553K | 49,120 | US |
| 378 | ACHAccendra Health, Inc. | Equity | 0.00% | $523K | 184,220 | US |
| 379 | TMCITreace Medical Concepts, Inc. Common Stock | Equity | 0.00% | $521K | 150,606 | US |
| 380 | ALECAlector, Inc. Common Stock | Equity | 0.00% | $495K | 229,241 | US |
| 381 | ORGOOrganogenesis Holdings Inc. Class A Common Stock | Equity | 0.00% | $486K | 189,147 | US |
| 382 | CTEVClaritev Corporation | Equity | 0.00% | $432K | 17,196 | US |
| 383 | TRDAEntrada Therapeutics, Inc. Common Stock | Equity | 0.00% | $404K | 57,115 | US |
| 384 | LYELLyell Immunopharma, Inc. Common Stock | Equity | 0.00% | $397K | 22,919 | US |
| 385 | QTRXQuanterix Corporation Common Stock | Equity | 0.00% | $381K | 124,660 | US |
| 386 | MXCTMaxCyte, Inc. Common Stock | Equity | 0.00% | $365K | 301,966 | US |
| 387 | HRTXHeron Therapeutics, Inc. | Equity | 0.00% | $362K | 415,508 | US |
| 388 | NMRANeumora Therapeutics, Inc. Common Stock | Equity | 0.00% | $333K | 179,998 | US |
| 389 | KRROKorro Bio, Inc. Common Stock | Equity | 0.00% | $292K | 21,772 | US |
| 390 | LENZLENZ Therapeutics, Inc. Common Stock | Equity | 0.00% | $271K | 34,870 | US |
| 391 | ALDXAldeyra Therapeutics, Inc. | Equity | 0.00% | $271K | 154,611 | US |
| 392 | HCATHealth Catalyst, Inc Common Stock | Equity | 0.00% | $220K | 159,364 | US |
| 393 | FLNAFilana Therapeutics, Inc. Common Stock | Equity | 0.00% | $203K | 132,117 | US |
| 394 | PLRXPliant Therapeutics, Inc. Common Stock | Equity | 0.00% | $193K | 153,162 | US |
| 395 | ALXOALX Oncology Holdings Inc. Common Stock | Equity | 0.00% | $185K | 97,449 | US |
| 396 | DCGODocGo Inc. Common Stock | Equity | 0.00% | $171K | 259,261 | US |
| 397 | GOSSGossamer Bio, Inc. Common Stock | Equity | 0.00% | $125K | 541,950 | US |
| 398 | DHDefinitive Healthcare Corp. Class A Common Stock | Equity | 0.00% | $105K | 112,535 | US |
| 399 | N/A | Derivative | 0.00% | $23K | 145,000 | |
| 400 | Hologic Inc | Equity | 0.00% | $2K | 162,940 | US |
| 401 | Roche Holding AG | Equity | 0.00% | $82 | 240 | CH |
| 402 | Prevail Therapeutics Inc | Equity | 0.00% | $39 | 78 | US |
| 403 | OABIWOmniAb, Inc. Warrant | Equity | 0.00% | $0 | 22,076 | US |
| 404 | OABIWOmniAb, Inc. Warrant | Equity | 0.00% | $0 | 22,076 | US |
| 405 | Chinook Therapeutics Inc | Equity | 0.00% | $0 | 784 | US |
| 406 | N/A | Derivative | -0.00% | −$44K | 14,408 | |
| 407 | N/A | Derivative | -0.00% | −$138K | 100,000 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | EXASExact Sciences Corp | 0.29% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | HOLXHologic Inc | 0.25% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RVMDREVOLUTION Medicines Inc | 0.21% | 0.40% | +15.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BTSGBrightSpring Health Services Inc | 0.06% | 0.14% | +48.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | FOLDAmicus Therapeutics Inc | 0.06% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ACLXArcellx Inc | 0.05% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | DNTHDianthus Therapeutics Inc | 0.01% | 0.05% | +119.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | TERNTerns Pharmaceuticals Inc | 0.04% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | MDLNMedline Inc | 0.12% | 0.15% | +56.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | SLNOSoleno Therapeutics Inc | 0.03% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | APLSApellis Pharmaceuticals Inc | 0.02% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CELCCelcuity Inc | 0.02% | 0.04% | +63.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | INDVIndivior Pharmaceuticals Inc | 0.04% | 0.06% | +21.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ORKAOruka Therapeutics Inc | 0.01% | 0.03% | +44.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | SHCSotera Health Co | 0.05% | 0.07% | +30.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | APGEApogee Therapeutics Inc | 0.03% | 0.05% | +19.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | NTLAIntellia Therapeutics Inc | 0.02% | 0.03% | +25.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CLDXCelldex Therapeutics Inc | 0.03% | 0.03% | +11.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | NKTRNektar Therapeutics | 0.02% | 0.03% | +26.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TRVITrevi Therapeutics Inc | 0.02% | 0.02% | +12.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RXRXRecursion Pharmaceuticals Inc | 0.02% | 0.03% | +20.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | INVAInnoviva Inc | 0.02% | 0.02% | +17.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BHVNBiohaven Ltd | 0.02% | 0.02% | +12.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ALMSAlumis Inc | 0.02% | 0.02% | +20.8% | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.